Find a Product

Ponatinib

Ponatinib (or Iclusig) is typically used for the treatment of chronic myeloid leukemia and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia.

Catalog No. Size Price Quantity
92-1315 10 mg $210.00

For account specific pricing, please contact Customer Service at customerservicedrx@eurofins.com.
Description
Ponatinib
Compound Type
Antagonist
Storage
-20°C
Source
Synthetic
Cells were plated in a 384-well plate and incubated overnight at 37°C/5% CO₂ to allow the cells to attach and grow. Cells were then stimulated with a control compound, using the assay conditions described below. Following treatment, signal was detected using the InCELL Hunter Detection Kit according to the recommended protocol.